ARK Genomic Revolution ETF vs ProShares Ultra QQQ ETF — how do they compare? ARK Genomic Revolution ETF trades at $44.88, while ProShares Ultra QQQ ETF trades at $92.74. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, ProShares Ultra QQQ ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | QLD | |
|---|---|---|
Sector | Sector/Thematic | Leveraged / Inverse |
52-Week High | $44.55 | $100.53 |
52-Week Low | $24.02 | $57.16 |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →QLD is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the NASDAQ-100 Index. It achieves 2x leverage by investing in financial instruments such as swaps and is designed as a tactical trading tool for investors with a bullish (long) view on the NASDAQ-100. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on QLD →